Chinnery Patrick F, Samuels David C, Elson Joanna, Turnbull Douglass M
Departments of Neurology, University of Newcastle upon Tyne, NE2 4HH, Newcastle upon Tyne, UK.
Lancet. 2002 Oct 26;360(9342):1323-5. doi: 10.1016/S0140-6736(02)11310-9.
In man, cells accumulate somatic mutations of mitochondrial DNA (mtDNA) as part of normal ageing. Although the overall concentration of mutant mtDNA is low in tissue as a whole, very high numbers of various mtDNA mutations develop in individual cells within the same person, which causes age-associated mitochondrial dysfunction. Some tumours contain high numbers of mtDNA mutations that are not present in healthy tissues from the same individual. The proportion of mutant mtDNA also rises in patients with progressive neurological disease due to inherited mtDNA mutations. This increase parallels the relentless clinical progression seen in these disorders. Mathematical models suggest that the same basic cellular mechanisms are responsible for the amplification of mutant mtDNA in ageing, in tumours, and in mtDNA disease. The accumulation of cells that contain high levels of mutant mtDNA may be an inevitable result of the normal mechanisms that maintain cellular concentrations of mtDNA.
在人类中,细胞会积累线粒体DNA(mtDNA)的体细胞突变,这是正常衰老过程的一部分。尽管在整个组织中突变型mtDNA的总体浓度较低,但同一个人体内的单个细胞中会出现大量各种各样的mtDNA突变,这会导致与年龄相关的线粒体功能障碍。一些肿瘤含有大量在同一个体的健康组织中不存在的mtDNA突变。由于遗传性mtDNA突变导致的进行性神经疾病患者中,突变型mtDNA的比例也会升高。这种增加与这些疾病中无情的临床进展平行。数学模型表明,相同的基本细胞机制导致了衰老、肿瘤和mtDNA疾病中突变型mtDNA的扩增。含有高水平突变型mtDNA的细胞积累可能是维持细胞内mtDNA浓度的正常机制的必然结果。